The Naval Health Research Center (NHRC) awarded a $76,722.88 firm fixed-price purchase order to Luminex Corp on August 14, 2025, for Luminex NxTAG Respiratory Pathogen Panel reagents and related MAGPIX system components. This sole-source award, issued under the statutory authority of 10 U.S.C. 3204(a)(1), procures critical respiratory pathogen testing supplies including 18 units of NxTAG Respiratory Pathogen Panel test kits, calibration and verification supplies, maintenance kits, and replacement components. The contract is funded by the Bureau of Medicine and Surgery, a Defense agency within the Department of the Navy, with performance to be completed by September 16, 2025, with additional scheduled deliveries through January 2026. The procurement falls under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC code 6632 (Medical Laboratory Analysis Instruments).
Luminex Corp, headquartered in Austin, Texas, is an established federal supplier specializing in multiplex diagnostic solutions and in-vitro diagnostic technologies. The company maintains significant federal contract vehicles including a $5.76 million blanket purchase agreement with the Department of the Air Force, a $250,000 indefinite delivery contract with the Department of Agriculture, and a $519,140 blanket purchase agreement with the Department of Veterans Affairs. Luminex's existing relationship with the Naval Health Research Center and Bureau of Medicine and Surgery, combined with its specialized expertise in respiratory pathogen testing platforms, supported the sole-source justification for this award. This purchase order represents a routine procurement of critical diagnostic supplies to support the Navy's clinical testing and public health surveillance capabilities.